CardioNet Files For IPO

San Diego-based CardioNet has filed for an IPO, saying in a filing with the SEC Friday that it is looking to raise up to $150M in an IPO on the Nasdaq Global Market. The firm, which is looking to trade under the symbol BEAT, develops medical devices used for monitoring patient health and heart arrhythmia. The IPO is being underwritten by Citi, CIBC World Markets, and SunTrust Robinson Humphrey. The firm is backed by Boston Scientific, Sanderling Ventures, H&Q Healthcare Investors, BioFrontier, and IngleWood Ventures.